Understanding Coagulation

Course Objectives
  1.  Explain how hemostasis relates to coagulation testing and bleeding control after venipuncture.
  2. Apply collection and handling practices that protect coagulation specimen integrity.
  3. Recognize bleeding risks and specimen concerns that require additional precautions or communication with the healthcare team.

Course Content
Course Creator: Jayne Vanderstelt
Total CE Hours: 1 Credit Hour 
Pace Course #:  586-3004-26 

Outline:
 
I. Hemostasis in Practice 
  • Brief review of the vessel response, platelet plug formation, fibrin formation, clot stabilization, and fibrinolysis.
  • Knowledge application: Assessing the puncture site when a patient says their platelet count is normal.
II. Understanding Coagulation Tests
  • What common and specialized tests evaluate, including PT/INR, aPTT, thrombin time, platelet count, D-dimer, fibrin degradation products, and von Willebrand testing.
  • Platelet clumping and recollection. Differences between factor V activity and Factor V Leiden testing.
  • Knowledge application: Clarifying an order labeled only Factor V before collecting.
III.Protecting Coagulation Specimen Integrity
  • Order verification, sodium citrate tube fill, order of draw, and winged collection devices.
  • Special collection considerations for elevated hematocrit and vascular access devices.
  • Specimen mixing, initial assessment, processing, transport, and recollection.
  • Knowledge applications: Responding to a delayed courier and managing an underfilled citrate tube for an urgent PT/INR.
IV. Bleeding and Clotting Concerns in Practice
  • Relevant patient history, medication use, collection precautions, and bleeding control after venipuncture.
  • Collection and testing considerations for platelet disorders, hemophilia, von Willebrand disease, anticoagulant therapy, and selected clotting disorders.
  • Knowledge application: Handling separate orders for PT/INR and protein C and protein S testing in a patient taking warfarin.
V. Key Takeaways
  • Verify the order and collection requirements.
  • Protect the specimen from collection through transport.
  • Confirm bleeding control and communicate unresolved concerns.

References:
  1. Streiff, M. B. (2025, September). Overview of hemostasis. Merck Manual Professional Edition. https://www.merckmanuals.com/professional/hematology/hemostasis/overview-of-hemostasis
  2. World Health Organization. (2010). WHO guidelines on drawing blood: Best practices in phlebotomy. https://www.who.int/publications/i/item/9789241599221
  3. Labcorp. (n.d.). Blood specimens: Coagulation. Retrieved November 3, 2026, from https://www.labcorp.com/test-menu/resources/blood-specimens-coagulation
  4. National Heart, Lung, and Blood Institute. (2022, March 24). Platelet disorders: What are platelet disorders?https://www.nhlbi.nih.gov/health/platelet-disorders
  5. Mayo Clinic Laboratories. (n.d.). D-dimer, plasma (DDITT). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40936
  6. Mayo Clinic Laboratories. (n.d.). Activated partial thromboplastin time, plasma (APTTP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40935
  7. Labcorp. (n.d.). Partial thromboplastin time (PTT), activated (005207). Retrieved November 3, 2026, from https://www.labcorp.com/tests/005207/partial-thromboplastin-time-ptt-activated
  8. Mayo Clinic Laboratories. (n.d.). Complete blood cell count (CBC) with differential, blood. Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/9109
  9. Labcorp. (n.d.). Platelet count (005249). Retrieved November 3, 2026, from https://www.labcorp.com/tests/005249/platelet-count
  10. Mayo Clinic Laboratories. (n.d.). Coagulation factor V activity assay, plasma (FACTV). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/9054
  11. Mayo Clinic Laboratories. (n.d.). Factor V Leiden (R506Q) mutation, blood (F5DNA). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/81419
  12. Labcorp. (n.d.). Fibrinogen degradation products (FDP), plasma (115402). Retrieved November 3, 2026, from https://www.labcorp.com/tests/115402/fibrinogen-degradation-products-fdp-plasma
  13. Mayo Clinic Laboratories. (n.d.). Prothrombin time, plasma (PTTP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40934
  14. Mayo Clinic Laboratories. (n.d.). Thrombin time (bovine), plasma (TTSC). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/602184
  15. Mayo Clinic Laboratories. (n.d.). von Willebrand disease profile, plasma (AVWPR). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/603550
  16. National Heart, Lung, and Blood Institute. (2023, March 24). Bleeding disorders: Diagnosis. https://www.nhlbi.nih.gov/health/bleeding-disorders/diagnosis
  17. National Heart, Lung, and Blood Institute. (2022, March 24). Platelet disorders: Thrombocythemia and thrombocytosis. https://www.nhlbi.nih.gov/health/thrombocythemia-thrombocytosis
  18. Mayo Clinic Laboratories. (n.d.). Lupus anticoagulant profile, plasma (ALUPP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/603463
  19. National Heart, Lung, and Blood Institute. (2022, March 24). Blood clotting disorders: Disseminated intravascular coagulation (DIC). https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
  20. Mayo Clinic Laboratories. (n.d.). Thrombophilia profile, plasma and whole blood (AATHR). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/603304